Causes Of Mdd - Pharma

Relevant Publications

The relationship between BDNF and physical activity on depression.

Issue Release: 2024

Hydroalcoholic Extract of Centella asiatica and Madecassic Acid Reverse Depressive-Like Behaviors, Inflammation and Oxidative Stress in Adult Rats Submitted to Stress in Early Life.

Issue Release: 2024

Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: An analysis of the global burden of disease study.

Issue Release: 2024

A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?

Issue Release: 2024

Functioning in patients with major depressive disorder in remission: A systematic review and meta-analysis.

Issue Release: 2024

Causes of death in individuals with lifetime major depression: a comprehensive machine learning analysis from a community-based autopsy center.

Issue Release: 2024

Evaluating the Efficacy of Telehealth-Based Treatments for Depression in Adults: A Rapid Review and Meta-Analysis.

Issue Release: 2024

Prospective Relations Between Inferential Styles and Depressive Symptoms Among Children of Mothers with Major Depression.

Issue Release: 2024

Depression unveiled: Insights into etiology and animal models for behavioral assessment, exploring the multifactorial nature and treatment of depression.

Issue Release: 2024

Interventionism and Intelligibility: Why Depression Is Not (Always) a Brain Disease.

Issue Release: 2024

Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.

Issue Release: 2024

A framework for inferring and analyzing pharmacotherapy treatment patterns.

Issue Release: 2024

Excess mortality and its causes among older adults with schizophrenia versus those with bipolar disorder and major depressive disorder: a 5-year prospective multicenter study.

Issue Release: 2024

N-(3-((3-(trifluoromethyl)phenyl)selanyl)prop-2-yn-1-yl) benzamide induces antidepressant-like effect in mice: involvement of the serotonergic system.

Issue Release: 2024

A qualitative, multi-perspective study on causal beliefs about adolescent depression.

Issue Release: 2024

Evaluation of the efficacy and safety of Yukwool-tang for major depressive disorder in women: A randomized, double blinded, placebo-controlled, parallel trial.

Issue Release: 2024

Longitudinal study on all-cause and suicide mortality among individuals with attention deficit hyperactivity disorder.

Issue Release: 2024

MRI-based deep learning for differentiating between bipolar and major depressive disorders.

Issue Release: 2024

Impact of psychiatric disorders on the risk of glioma: Mendelian randomization and biological annotation.

Issue Release: 2024

Cause-specific mortality in treatment-resistant major depression: Population-based cohort study.

Issue Release: 2024

Why is Regulatory Approval Important?

What are the Implications for Pharma Companies?

How Do Collaborative Care Models Work?

What are Contract Research Organizations (CROs)?

How Do Pharmacists Contribute to Patient Care?

How Can Technology Aid in Management?

Why is Medication Management Important?

Why are Collaborative Care Models Important in Pharma?

What are Collaborative Care Models?

What Should Be Included in Patient Education Materials?

Partnered Content Networks

Relevant Topics